MERCY REGIONAL CANCER CENTER 2012 CANCER PROGRAM ANNUAL REPORT Using 2011 Data
Mercy Regional Cancer Center When you have cancer, you might think first of treatments chemotherapy and radiation. You want and need both of these to be at the highest level, with the most advanced technologies and techniques, with cancer doctors who are not only experts in their field, but compassionate and caring. You will find all of that and more at Mercy Cancer Center in Lorain County. We serve the needs of people with cancer throughout northeastern Ohio. Guided by a holistic philosophy, our multidisciplinary team of board certified radiation oncologists, medical oncologists and hematologists devise individualized, targeted treatment plans based on the latest clinical guidelines. State of the art radiation oncology services: We are the only facility in Lorain County to provide Intensity Modulated Radiation Therapy and Image Guided Radiotherapy, for more precise targeting and greater preservation of healthy tissue. Latest hematology oncology services: Board certified hematologists and medical oncologists offer the latest in chemotherapy treatments for curing, controlling or relieving symptoms of cancer. Holistic care offered through The Center for Body, Mind and Spirit: Mercy s Center for Body, Mind and Spirit is a unique center that focuses on the psychological, emotional, spiritual and social aspects of healing through the programs and services offered. Patients and families can learn to soothe the mind, nurture the spirit and care for the soul. Many programs and services are free to anyone touched by cancer. 1 P age
CANCER CONFERENCE Cancer conferences provide a multidisciplinary forum for the medical staff at Mercy Regional Medical Center to review cancer cases in an informative and educational setting to improve the quality of cancer patient care. Medical specialties attending Cancer Conferences include Surgery, Medical Oncology, Radiation Oncology, Pathology, and Diagnostic Radiology. In 2012, 21 Cancer Conferences were held with 50 cases reviewed in 2012 and included the top five sites seen most frequently at Mercy Regional Medical Center. CANCER COMMITTEE The cancer committee is made up of representatives from each specialty that participates in a cancer patient s care. Departments represented include physicians and specialists as well as allied health fields. The Committee is dedicated to establishing and maintaining the accredited cancer program with the focus of assisting patients and their families through continuum of care. The Cancer Committee oversees the cancer programs goals, develops studies, initiates improvements and is involved with cancer centered activities throughout the facility. 2 P age
MERCY REGIONAL CANCER COMMITTEE MEMBERS Sylvia Radziszewski, MBA RRT Belagodu Kantharaj MD Andrew O Leary DO Beverly Paige, MD Albin Gonzalez, Ph.D., DABR Darlene Brown, RN Faizi Ali MD Chad Cohen MD Deanna Petruchik Kathy Grueschow, RN Vikki Howard LSW Nancy Stoldt, RN Judy Strandahl CTR Cathy Fior, RN Robert Sprosty, RN Dr. Zaworski Deanna Schreiber, LPT Sherry Van Gilder, RD Cancer Program Administrator Medical Oncology / Cancer Committee Chair Radiation Oncology/ Cancer Liaison Physician General Surgery Physicist Radiation Oncology Oncology Nursing Pathology Diagnostic Radiology Cancer Conference Coordinator Community Outreach Coordinator Psychosocial Coordinator Quality Improvement Coordinator Cancer Registry / Cancer Quality Women s Center Clinical Research Coordinator Hospice Services Rehabilitation Services Dietary Services 3 P age
CANCER REGISTRY REPORT 2012 The primary goal of the Cancer Registry is to collect and maintain complete and accurate data on cancer patients diagnosed and/or treated at Mercy Regional Medical Center. Data collected by the cancer registry is an invaluable tool in the fight against cancer. As an accredited CoC facility the registry collects demographic and disease specific data elements on each cancer patient presenting for diagnosis or treatment. The information collected is utilized by physicians, administration, and other healthcare professionals. Among the many uses are: measuring quality outcomes tracking community outreach initiatives supporting clinical, diagnostic, and treatment research evaluating the effectiveness of current treatment modalities presenting data for individualized patient treatment planning submitting to local and national databases for incidence and outcome comparison The following graph illustrates the most frequent primary sites seen at this facility. TOP FIVE PRIMARY SITES 2011 ANALYTIC CASES SITE PERCENTAGE BREAST 29% LUNG 19% COLON 9% PROSTATE 8% NON HODGKINS 4% 4 P age 266 FEMALE 211 MALE MAJORITY OF PATIENTS AGE AT DIAGNOSIS 60-69 YEARS OF AGE
CANCER REGISTRY REPORT 2012 FEMALE SITE DISTRIBUTION Breast was the most frequent primary to be accessioned in the registry for female patients seen at MRMC for 2011 followed by lung, colon, uterine and Non Hodgkin s lymphoma. FEMALE Top Five Female Cancer Sites 2011 BREAST 51% LUNG 14% COLON UTERINE NON HOD LYMPHOMA 6% 5% 5% 0% 20% 40% 60% MALE SITE DISTRIBUTION Lung was the most frequent primary to be accessioned into the registry for male patients seen at MRMC in 2011 (27%) followed by prostate, colon, bladder and oral carcinoma Top Five Male Cancer Sites 2011 LUNG 27% PROSTATE 18% COLON 12% BLADDER 7% ORAL CARCINOMA 4% 0% 10% 20% 30% 5 P age
CANCER REGISTRY REPORT 2012 The majority of patients diagnosed at Mercy Regional Medical Center in 2011 were within the age groups of 60 and 69. Age distribution for 2011 patients seen at Mercy Regional Medical Center as compared to the National Cancer Data Base is illustrated in the following graph: 35% MRMC AGE AT DIAGNOSIS 2011 30% 25% 20% 15% 10% 5% 0% < 20 20 29 30 39 40 49 50 59 60 69 70 79 80 89 90 + FTMC NCDB 2011 MRMC AGE AT DIAGNOSIS VS NCDB 2010 ANALYTICAL 6 P age
MERCY REGIONAL SITE DISTRIBUTION MERCY REGIONAL MEDICAL CENTER PRIMARY SITE TABULATION FOR 2011 PRIMARY SITE TOTAL SEX AJCC STAGE GROUP M F 0 I II III IV UNK N/A ALL SITES 477 211 266 35 127 82 69 98 33 33 TONGUE 5 4 1 0 0 0 1 4 0 0 OTHER ORAL 11 9 2 0 1 1 3 3 3 0 ESOPHAGUS 6 5 1 0 0 0 2 2 2 0 STOMACH 4 3 1 0 1 0 1 1 1 0 COLON 41 26 15 2 11 6 9 12 1 0 RECTUM 10 6 4 0 1 1 2 1 5 0 PANCREAS 6 2 4 0 0 0 0 6 0 0 OTHER DIGESTIVE 2 1 1 0 1 0 0 0 0 1 LARYNX 5 5 0 0 1 1 3 0 0 0 LUNG/BRONCHUS 92 56 36 0 10 5 29 43 5 0 OTHER RESPIRATORY 4 3 1 0 0 0 2 1 1 0 LEUKEMIA 4 3 1 0 0 0 0 0 0 4 MULTIPLE MYELOMA 2 1 1 0 0 0 0 0 0 2 OTHER BLOOD 2 1 1 0 0 0 0 0 0 2 CONNECT/SOFT TISSUE 1 1 0 0 0 1 0 0 0 0 MELANOMA 5 3 2 0 1 1 1 2 0 0 OTHER SKIN 2 2 0 0 0 0 0 0 1 1 BREAST 138 3 135 24 61 28 10 6 9 0 CERVIX UTERI 2 0 2 0 1 0 0 1 0 0 CORPUS UTERI 14 0 14 0 9 2 0 1 2 0 OVARY 0 0 0 0 0 0 0 0 0 0 VULVA 3 0 3 2 0 1 0 0 0 0 OTHER FEMALE 0 0 0 0 0 0 0 0 0 0 PROSTATE 39 39 0 0 11 25 0 2 1 0 OTHER MALE 1 1 0 0 1 0 0 0 0 0 BLADDER 18 14 4 7 5 4 0 1 1 0 KIDNEY/RENAL 3 2 1 0 1 0 0 2 0 0 BRAIN (MALIGNANT) 2 2 0 0 0 0 0 0 0 2 OTHER BRAIN 4 2 2 0 0 0 0 0 0 4 THYROID 12 2 10 0 5 2 4 1 0 0 OTHER ENDOCRINE 6 2 4 0 0 0 0 0 0 6 HODGKIN'S DISEASE 2 1 1 0 0 1 0 1 0 0 NON-HODGKIN'S 19 7 12 0 6 3 2 8 0 0 UNKNOWN PRIMARY 11 5 6 0 0 0 0 0 0 11 OTHER/ILL-DEFINED 1 0 1 0 0 0 0 0 1 0 7 P age
COMMUNITY CANCER PROGRAM PRACTICE PROFILE REPORTS (CP3R) FOR BREAST, COLON AND RECTAL CARCINOMA Standard 4.4 Accountability Measures 2010 Breast Cancer Measures for First Course Treatment MRMC Treatment Measure Definition MRMC Radiation Therapy (RT) Chemotherapy (MAC) Hormone Therapy (HT) RT within 365 days for women under 70 years of age with breast conserving surgery MAC within 120 days of diagnosis under 70 years of age with AJCC T1, NO, MO or Stage 2/3 (ER and PR negative) HT given within 365 days for women with AJCC T1c, NO, MO or Stage 2/3 (ER and PR positive) 93% 100% 91% 2010 Colon and Rectum Measures for First Course Treatment MRMC Treatment Measure Definition MRMC Chemotherapy (MAC) 12 Regional Lymph Nodes Removed (12RLN) MAC within 120 days of diagnosis under 80 years of age with AJCC Stage 3 (lymph node positive) 12RLN: At least 12 regional lymph nodes removed and pathologically examined 75% 78% Radiation Therapy for Rectal Cancer (AdjRT) Adjuvant RT considered/administered within 180 days of diagnosis for patients under 80 years with clinical or pathologic AJCC T4, NO, MO or Stage 3 receiving surgical resection for rectal cancer No Cases 8 P age
RESOURCES American Cancer Society (ACS) www.cancer.org American College of Surgeons (ACoS) http://www.facs.org/cancer/index.html College of American Pathologists www.cap.org American Joint Committee on Cancer (AJCC) www.cancerstaging.org National Cancer Institute (NCI) www.nci.nih.gov The Mercy Cancer Center in Lorain County has full accreditation from: The American College of Surgeons Commission on Cancer The Joint Commission on Accreditation of Healthcare Organizations American College of Radiology (ACR) Breast Excellence For information about the Mercy Cancer Center, please call 440 324 0400. 9 P age